Medication

How Weight Loss Medications Work: A Medical Overview

Weight loss medications support the body’s natural appetite and hormone systems. Learn how treatments like Wegovy and Mounjaro work, their benefits, limitations, and what to expect.

5 min read
How Weight Loss Medications Work: A Medical Overview

Weight loss is often framed as a simple matter of willpower, but medical research has shown that body weight is regulated by complex biological systems involving hormones, appetite signalling, metabolism, and the brain. For many people, these systems work against sustained weight loss, even with significant effort around diet and exercise.

Weight loss medications are designed to support these underlying biological processes. Rather than forcing weight loss, they help regulate appetite, improve fullness, and reduce the constant drive to eat that many people experience. For a more detailed explanation of how these hormone systems work, see our article What Are GLP-1 Medications and Why Do They Help With Weight Loss.

Understanding appetite and weight regulation
The body tightly controls weight through hormonal signals between the gut, brain, and fat tissue. Hormones such as GLP-1 play a key role in signalling fullness after eating and slowing how quickly food leaves the stomach.

In people living with obesity, these signals may be less effective, which can make hunger feel persistent and weight regain more common.

How medications like Wegovy and Mounjaro help
Medications such as Wegovy (semaglutide) and Mounjaro (tirzepatide) work by enhancing these natural satiety signals. These treatments belong to a group of medications known as GLP-1 based therapies, which are explained in more detail in our guide What Are GLP-1 Medications and Why Do They Help With Weight Loss.

Wegovy mimics the action of the GLP-1 hormone, helping people feel fuller sooner, reducing appetite, and lowering calorie intake over time.

Mounjaro acts on both GLP-1 and GIP receptors, offering dual appetite and metabolic support for some individuals.

Emerging treatments
Retatrutide is a newer medication currently in clinical trials. It targets multiple hormone pathways and may lead to greater average weight loss, but it is not yet approved for routine use in the UK.

Potential side effects and considerations
Common side effects include nausea, vomiting, diarrhoea, constipation, and reduced appetite. These effects are usually temporary and improve with gradual dose increases. Medical assessment is essential to ensure safety and suitability. We cover this in more detail in our guide to side effects of weight loss medication.

Medication as part of a wider plan
Weight loss medication works best as part of a broader approach that includes nutrition, movement, sleep, and mental wellbeing support. For a complete overview, see our main guide Weight Loss Medication in the UK: A Patient-Centred Pillar Guide.

Further reading
• NICE guidance on obesity management
• NHS weight management services
• Clinical trials for semaglutide and tirzepatide

Get weekly weight loss tips

Join our newsletter for provider updates, expert guidance, and exclusive offers — no spam.

Subscribe free